摘要
目的:比较奎硫平与利培酮治疗晚发精神分裂症患者的临床疗效和安全性。方法:对60例晚发精神分裂症的住院患者随机分为两组,分别用奎硫平和利培酮治疗8周。采用阳性与阴性症状量表(PANSS)评定疗效,用副反应量表(TESS)评定不良反应。结果:奎硫平与利培酮治疗晚发精神分裂症患者的临床疗效差异无显著性。两组不良反应均少而轻。结论:奎硫平治疗晚发精神分裂症疗效好,起效快,不良反应少。
Objective：To compare the efficacy and safety between quetiapinc and risperidone in the treatment of late onset schizophrenia. Method： 60 late onset schizophrenias were randomly divided into two groups. They received quetiapine and risperidone respectively for 8 weeks. The efficacies and side effects were assessed by positive and negative symptom scale （PANSS）, treatment emengent symptom scale （TESS）. Results：The efficacies of both quetiapine and fisperidone to treat late onset schizophrenias were similar, side effects were fewer and milder, Conclusion： Quetiapine is an effective and safe drug in the treatment of late onset schizophrcnias. Its side effects were fewer.
出处
《临床精神医学杂志》
2006年第1期34-35,共2页
Journal of Clinical Psychiatry
关键词
奎硫平
利培酮
晚发精神分裂症
quetiapine
riperidone
late onset schizophrenia
